Mortality associated to hematological malignancies across pandemic waves in 2020: A nationwide analysis of multiple causes of death in Italy.

This article examines the impact of the COVID-19 pandemic on mortality rates associated with hematological malignancies in Italy. The study found that deaths with any mention of hematological malignancies increased in 2020 compared to the previous year, while deaths classified as the underlying cause of death declined. The increase in mortality was most pronounced for chronic lymphocytic leukemia (CLL) and less prominent for non-Hodgkin lymphoma (NHL) and multiple myeloma (MM). The study highlights the importance of considering multiple causes of death in assessing the mortality burden in hematological patients during the pandemic. [Extracted from the article]